The regulation of translation has been investigated in yeast cells by means of ionophores and other compounds affecting the ionic concentration inside the cell. Treatment of a variety of cells with these compounds produces a drastic inhibition in the protein-synthesizing activity of the cell. Protein synthesis in yeast is strongly inhibited by amphotericin B and nystatin. Mammalian cells are blocked in their translation capacity by gramicidin D, nigericin, monensin, nystatin, A23187, and bromolasalocid. The effects of these compounds on protein synthesis in Escherichia coli and Staphylococcus aureus were also investigated. Amphotericin B is a powerful inhibitor of both protein and ribonucleic acid syntheses in yeast cells at concentrations that do not affect the transport of the labeled amino acid or nucleoside precursor. The analysis of the polysomal profiles in yeast spheroplasts could indicate that initiation is the target of amphotericin B action on translation. Studies on the reversion of the protein synthesis blockade by amphotericin B by increasing the potassium concentration in the medium suggest that changes in the potassium concentration in cellular cytoplasm might be responsible, at least in part, for the inhibition of protein synthesis.
The regulation of translation has been investigated in yeast cells by means of ionophores and other compounds affecting the ionic concentration inside the cell. Treatment of a variety of cells with these compounds produces a drastic inhibition in the protein-synthesizing activity of the cell. Protein synthesis in yeast is strongly inhibited by amphotericin B and nystatin. Mammalian cells are blocked in their translation capacity by gramicidin D, nigericin, monensin, nystatin, A23187, and bromolasalocid. The effects of these compounds on protein synthesis in Escherichia coli and Staphylococcus aureus were also investigated. Amphotericin B is a powerful inhibitor of both protein and ribonucleic acid syntheses in yeast cells at concentrations that do not affect the transport of the labeled amino acid or nucleoside precursor. The analysis of the polysomal profiles in yeast spheroplasts could indicate that initiation is the target of amphotericin B action on translation. Studies on the reversion of the protein synthesis blockade by amphotericin B by increasing the potassium concentration in the medium suggest that changes in the potassium concentration in cellular cytoplasm might be responsible, at least in part, for the inhibition of protein synthesis.
The molecular mechanism by which the translation machinery is regulated in the cell is not yet well understood. It is obvious that some mechanisms must operate in the cell to regulate protein synthesis under physiological conditions (8, 11, 12, 16) , and the target of such regulation seems to be at the initiation of messenger ribonucleic acid (RNA) translation (11) . Different lines of evidence idicate that in this regulation the structure of the ribosome binding site of the messenger RNA plays an important role (16) . On the other hand, overwhelming evidence from in vitro systems indicates that the phosphorylation of several initiation factors and ribosomal proteins (11) influences the capacity of cell-free systems to synthesize proteins (16) . However, there is no in vivo evidence as yet to support such a phosphorylation mechanism in intact cells under different physiological conditions. It has also been observed that monovalent ions can specifically affect the in vitro translation of several messenger RNAs in such a way that the translation of some of them is strongly inhibited by those ions, whereas the translation of other messenger RNAs is stimulated (4). These findings correlate with the changes in the permeability of the membrane to ions observed in vivo when changes in protein synthesis occur (3, 4).
These observations have led us to investigate the possible relationship between changes in plasma membrane activity distorting the ionic concentration in the cytoplasm membrane, modifying the gradient of ions and protons maintained by cellular membranes (3, 15) . By using these compounds we sought to answer the following questions. (i) Is there a direct relationship between plasma membrane integrity and the translation capacity of the cells? (ii) What step in translation is affected by modification of the ionic composition of cellular cytoplasm? (iii) What is the actual mediator between the changes in membrane integrity and the proteinsynthesizing apparatus?
MATERIALS AND METHODS
Saccharomyces cerevisiae Y166 was used throughout this work. It is the haploid mating type a, auxotrophic for histidine and tryptophan, and unable to ferment maltose. The celLs were grown in YEP medium (6) and subcultivated once a day by adding 0.2 ml of stationary cultures to 10 ml of fresh medium and incubated with shaking at 30°C. Krebs II ascites cells were taken from mice previously injected with ascitic tumor liquid. Escherichia coli and Staphylococcus aureus cells were employed as described in Table 1 VOL. 16, 1979 on October 16, 2017 by guest http://aac.asm.org/ Figure 3 illustrates the dependence of cell concentration on amphotericin B inhibition. Under the conditions used, 50% inhibition is achieved at an average of 5 x 108 molecules of amphotericin B per cell. The time course of amphotericin B and nystatin action is shown in Fig. 4 . It should be noted that although nystatin exerted its action almost immediately after its addition to the medium (Fig. 4B) (Table 2) .
It is well known that amphotericin B disturbs the gradient of ions maintained by the plasma membrane (5, 15). In addition, it interferes with the transport through the membrane of several metabolites. It was therefore of interest to determine whether the inhibition of translation observed was due to a direct effect on the protein-synthesizing machinery, or whether inhibition in the transport of methionine was the target for translation blocking. Hence, the methionine pool was determined (Table 3) . No effect whatsoever was seen, even when a concentration of amphotericin B as high as 1.3 x 1O-5 was used. Under similar conditions the inhibition of protein synthesis was complete (see Fig.  1 to 4) . We therefore conclude that the inhibitory effect on translation is not due to inhibition of transport of the radioactive precursor.
Step in translation blocked by amphoter- (Fig. 5) indicate that an increase in monosomes, with a concomitant decrease in polysomes, occurs at the time when inhibition of protein synthesis is observed. The "freezing" of polysomal profiles indicates an inhibition in the elongation or termination steps in protein synthesis, whereas polysome run-off suggests inhibition at the level of initiation (17) . In the light of these considerations, it seems that amphotericin B treatment acts by interfering with some step in the initiation process of translation. Evidence for this indication cannot be obtained from cell-free systems, because all the compounds used in this work are absolutely inactive when tested in cellfree protein-synthesizing systems (unpublished data). These results are in contrast with previous work by Herzberg et al. (7) , who suggest that VOL. 16, 1979 on October 16, 2017 by guest http://aac.asm.org/ Reversibility by potassium ions of the amphotericin B-induced inhibition of translation. The third question concerns the actual mechanism by which amphotericin B modification of the membrane was able to cause such strong inhibition of protein synthesis. It is assumed that a mediator between the plasma membrane and the protein-synthesizing apparatus is responsible for such an effect. Some workers have considered the possibility that a protein bound to the membrane could detach and bind to ribosomes blocking their activity (2, 7). However, this hypothesis does not explain the variety of cell functions influenced by amphotericin B treatment, mainly protein synthesis (Fig. 1 to 4 ), RNA synthesis (Table 2) , respiration, transport of several metabolites, oxidative phosphorylation, etc. As a likely candidate we considered that the loss of potassium ions occurring after amphotericin B binding to the cells could be, at least in part, responsible for the observed blockade of protein synthesis initiation in yeast cells. To test this possibility we tried to reverse the inhibition ofprotein synthesis caused by amphotericin B by addition of potassium chloride to the medium. This treatment was indeed able to reverse the inhibition of translation (Fig. 6 ). Figure 6A shows that treatment of the cells with amphotericin B for 90 min caused a 75% inhibition of protein synthesis, whereas no inhibition was observed at this time if 100 mM KCI was present. However, a gradual inhibition of protein synthesis was observed after that time even in the presence of KCI, probably indicating that other cellular functions affected by amphotericin B treatment, such as oxidative phosphorylation, adenosine triphosphate depletion, and metabolite leakage, begin to influence translation at later times. Figure 7 shows the specificity of this reversion. Neither NaCl nor MgCl2 was able to reverse the inhibition, whereas KCI was very effective. The partial reversion seen in the presence of CaCl2 is most probably due to its ability to complex amphotericin B, forming a complex that is unable to interact with the cell (5).
DISCUSSION
The membrane-active compounds used in the present work all produce changes in the gradient of ions maintained by the cell membrane (15 lation to continue. However, after longer incubation times, the leakage of other compounds essential to the cell would also influence protein synthesis.
We believe that our results showing the inhibition of translation by the presence of ionophores are better explained by ionic changes that occur in the cytoplasm (12) , rather than by any modification of the protein-synthesizing apparatus such as phosphorylation of factors or ribosomes, or the generation of stable inhibitors of translation (11, 16) .
